Erratum: ROPES eye plaque brachytherapy dosimetry for two models of 103Pd seeds (Australasian Physical and Engineering Sciences in Medicine (2011) 34 (223-231) DOI: 10.1007/s13246-011-0069-1));ROPES eye plaque brachytherapy dosimetry for two models of 103Pd seeds

Australasian Physical and Engineering Sciences in Medicine

Volumn 34, Issue 2, 2011, Pages 223-231

  Saidi, Pooneh ^a   Sadeghi, Mahdi ^d   Shirazi, Alireza ^b   Tenreiro, Claudio ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSIDAD DE TALCA   (Chile)

^d NONE

Author keywords

Brachytherapy; Dosimetry; Eye plaque

Indexed keywords

DOSIMETRY; INTELLIGENT SYSTEMS; MONTE CARLO METHODS; ONCOLOGY; PALLADIUM; RADIOTHERAPY; ROPE;

BRACHYTHERAPY; DOSE DISTRIBUTIONS; DOSE ENHANCEMENTS; DOSE REDUCTION; DOSIMETRIC PARAMETER; EYE PLAQUE; PLAQUE BRACHYTHERAPY; POINTS OF INTEREST;

STAINLESS STEEL;

PALLADIUM; RADIOISOTOPE; STAINLESS STEEL;

ARTICLE; BIOLOGICAL MODEL; BRACHYTHERAPY; CHOROID TUMOR; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; HUMAN; INSTRUMENTATION; MELANOMA; METHODOLOGY; MONTE CARLO METHOD; RADIATION DOSE;

BRACHYTHERAPY; CHOROID NEOPLASMS; COMPUTER SIMULATION; HUMANS; MELANOMA; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PALLADIUM; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; STAINLESS STEEL;

EID: 80051687629     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13246-011-0094-0     Document Type: Erratum

References (37)

1. C Grin-Jorgensen A Berke M Grin 1992 Ocular melanoma Dermatol Clin 10 663 668 1395150 1:STN:280:DyaK3s%2FgvFWlsQ%3D%3D
2. DM Robertson 2003 Changing concepts in the management of choroidal melanoma Am J Ophthalmol 136 161 170 12834684 10.1016/S0002-9394(03)00265-4 (Pubitemid 36794509)
3. PT Finger 1997 Radiation therapy for choroidal melanoma Surv Ophthalmol 42 215 232 9406368 10.1016/S0039-6257(97)00088-X 1:STN:280: DyaK1c%2FmvFCnsA%3D%3D (Pubitemid 27509826)
4. S Nag J Quivey J Earle D Followill J Fontanesi PT Finger 2003 The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas Int J Radiat Oncol Biol Phys 56 544 555 12738332 10.1016/S0360- 3016(03)00006-3 (Pubitemid 36542915)
5. DH Char S Kroll JM Quivey J Castro 1996 Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy Br J Ophthalmol 80 117 124 8814740 10.1136/bjo.80.2.117 1:STN:280:DyaK283ks1Cjsw%3D%3D (Pubitemid 26058543)
6. 125I brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no. 16. Ophthalmology 108:348-366 (Pubitemid 32115968)
7. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM (2001) The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma. III: initial mortality findings COMS Report No. 18. Arch Ophthalmol 119:969-982 (Pubitemid 32652189)
8. Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP et al (2002) The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy COMS report no. 19. Ophthalmology 109:2197-2206 (Pubitemid 35417099)
9. Heikkone J, Summanen P, Immonen I, Tommila P, Toivola H, Forss M et al (1992) Radiotherapy of malignant melanoma of the uvea with I-125 seeds. Acta Ophthalmol (Copenh) 70:780-785 (Pubitemid 23029615)
10. DM Robertson J Earle JA Anderson 1983 Preliminary observations regarding the use of iodine125 in the management of choroidal melanoma Trans Ophthalmol Soc UK 103 155 160 6582667 (Pubitemid 14188023)
11. S Packer M Rotman 1980 Radiotherapy of choroidal melanoma with iodine-125 Int Ophtalmol Clin 20 135 142 1:STN:280:DyaL3c3kvVOrsA%3D%3D
12. EJ Hall DJ Brenner 1991 The dose rate effect revisited: radiobiological considerations of importance in radiotherapy Int J Radiat Oncol Biol Phys 21 1403 1414 1938548 10.1016/0360-3016(91)90314-T 1:STN:280:DyaK38%2FktFWntw%3D%3D
13. PT Finger A Berson A Szechter 1999 Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7 years study Ophthalmology 106 606 613 10080222 10.1016/S0161-6420(99)90124-0 1:STN:280:DyaK1M7nvVejtQ%3D%3D (Pubitemid 30191600)
14. PT Finger DM Moshfeghi TK Ho 1991 Palladium-103 ophthalmic plaque radiotherapy Arch Ophthalmol 109 1610 1613 1755746 1:STN:280: DyaK38%2FpsFyntQ%3D%3D
15. P Saidi M Sadeghi A Shirazi C Tenreiro 2010 Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source Med Phys 37 2509 2515 20632562 10.1118/1.3416922 1:CAS:528:DC%2BC3cXntVyks7c%3D
16. 125I seed Med Phys 17 172 178 2333043 10.1118/1.596588 1:CAS:528:DyaK3cXktlOisro%3D (Pubitemid 20140134)
17. A Wu ES Sternick DJ Muise 1988 Effect of gold shielding on the dosimetry of an 125-I seed at close range Med Phys 15 627 628 3211059 10.1118/1.596218 1:STN:280:DyaL1M%2Fps1KmsQ%3D%3D
18. 125I for ophthalmic plaque dosimetry Med Phys 15 397 400 3405144 10.1118/1.596238 1:CAS:528:DyaL1cXltVSnu7s%3D
19. 103Pd eye plaque brachytherapy Med Phys 35 5530 5543 19175111 10.1118/1.3002412 1:CAS:528:DC%2BD1cXhsVentbnE
20. 125I seed (model 6711) in eye plaque Med Phys 20 383 389 8497229 10.1118/1.597164 1:STN:280:DyaK3s3mvVWmtw%3D%3D (Pubitemid 23136207)
21. 125I seed eye plaques Med Phys 13 78 83 3814235 10.1118/1.595926 1:STN:280:DyaL287ks1eqtw%3D%3D (Pubitemid 16185625)
22. 125I plaque dose distribution including penumbra characteristics Med Phys 23 407 418 10.1118/1.597803 (Pubitemid 26095697)
23. D Granero J Perez-Calatayud F Ballester E Casal 2004 Dosimetric study of the 15 mm ROPES eye plaque Med Phys 31 3330 3336 15651616 10.1118/1.1812605 1:STN:280:DC%2BD2M%2FisVyqsw%3D%3D (Pubitemid 40064985)
24. MJ Rivard BM Coursey LA DeWerd WF Hanson MS Huq GS Ibbott MG Mitch R Nath JF Williamson 2004 Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations Med Phys 31 633 674 15070264 10.1118/1.1646040 (Pubitemid 38381028)
25. 103Pd interstitial brachytherapy source Med Phys 27 643 654 10798684 10.1118/1.598924 1:CAS:528:DC%2BD3cXjtFehtLY%3D (Pubitemid 30227039)
26. 103Pd eye plaque brachytherapy with various seed models Med Phys 37 368 376 20175499 10.1118/1.3271104 1:CAS:528:DC%2BC3cXisVSmug%3D%3D
27. Monte Carlo Team, MCNP-A General Monte Carlo N-Particle Transport Code-Version 5, Los Alamos National Laboratory, http://mcnp-green.lanl.gov/ index.html, (last reviewed 29-Jan-2004)
28. 103Pd brachytherapy source Med Phys 35 1288 1294 18491522 10.1118/1.2870229 1:CAS:528:DC%2BD1cXktlGksLw%3D (Pubitemid 351457495)
29. 131Cs Med Phys 35 3364 3371 18697560 10.1118/1.2940604 1:CAS:528:DC%2BD1cXnvVGqs7g%3D (Pubitemid 351904539)
30. CC Popescu J Wise K Sowards AS Meigooni GS Ibbott 2000 Dosimetric characteristic of the Pharma Seed model BT-125-I source Med Phys 27 2174 2181 11011748 10.1118/1.1289897 1:STN:280:DC%2BD3cvltlCqtQ%3D%3D
31. E Kouwenhoven R Laarse DR Schaart 2001 Variation in interpretation of the AAPM TG-43 geometry factor leads to unclearness in brachytherapy dosimetry Med Phys 28 1965 1966 11585228 10.1118/1.1398563 1:STN:280:DC%2BD3MrjvVClsw%3D%3D (Pubitemid 32899737)
32. 103Pd brachytherapy source Med Phys 28 2568 2575 11797962 10.1118/1.1414007 1:STN:280:DC%2BD38%2FntFOnuw%3D%3D (Pubitemid 34031545)
33. JA Bearden AF Burr 1967 Reevaluation of X-ray atomic energy levels Rev Med Phys 39 125 142 10.1103/RevModPhys.39.125 1:CAS:528:DyaF2sXntVegtQ%3D%3D
34. ICRU (1992) Photon, Electron, Photon and Neutron Interaction Data for Body Tissues, ICRU Report 46. ICRU, Washington DC
35. 103palladium brachytherapy source Med Phys 26 2465 2470 10587234 10.1118/1.598765 1:CAS:528:DyaK1MXotV2gs70%3D
36. 103Pd source Med Phys 27 1108 1112 10841416 10.1118/1.598975 1:STN:280:DC%2BD3cvlvFylsg%3D%3D (Pubitemid 30350022)
37. 103Pd seeds with air kerma strength calibration based upon a primary national standard Med Phys 27 655 658 10798685 10.1118/1.598925 1:CAS:528:DC%2BD3cXjtFehtLc%3D (Pubitemid 30227040)